Клінічні характеристики та якість життя пацієнтів з ішемічною хворобою серця перед реваскуляризацією міокарда

Ю.А. Борхаленко, О.Й. Жарінов, Н.Б. Іванюк, К.О. Міхалєв, О.П. Надорак, О.А. Єпанчінцева, Б.М. Тодуров

Література

1. 1. Myasoyedova NA, Tkhostova EB, Belousov YuB. Assessment of the quality of life for various cardiovascular diseases. Qualitative Clinical Practice. 2002;1:10-14. (in Rus.).
   2. Pogosova NV. Aortocoronary shunting operation: influence on various aspects of quality of life of patients. Cardiology. 1998;1:81-88. (in Rus.).
   3. Pogosova NV, Baichorov IKh, Yufereva YuM, Koltunov IE. Quality of life of patients with cardiovascular diseases: the current state of the problem. Cardiology. 2010;4:66-78. (in Rus.).
   4. Yagensky AV, Höfer S, Sichkaruk ІМ, Oldridge N. Otsіka іnchastі zhіtya u pаtsієntіv zіshemіchnuyu hvoroboyu sercya: the results of the valuation of the Ukrainian food store MacNew Heart Disease Health-related Quality of Life. Ukr Cardiol J. 2013;3:22-28. (in Ukr.).
   5. Abdallah М, Wang K, Magnuson E, et al. Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial. JAMA. 2013;310:1581-1590.
   6. ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery. Circulation. 2004;110:1168-1176.
   7. Austin BA, Wang Y, Smith GL, et al. Systolic function as a predictor of mortality and quality of life in long-term survivors with heart failure. Clin Cardiol. 2008;31:119-124.
   8. ESC/EACTS Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg. 2014;46 (4):517-592.
   9. Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. New Engl J Med. 2012;367. Р. 2375-2384.
   10. Gupta D, Castagno D, Granger C, et al. Prognostic impact of an ischemic etiology of chronic heart failure across the spectrum of ejection fractions in the charm program. J Cardiac Failure. 2012;18:78.
   11. Hoekstra T, Lesman-Leegte I, van Veldhuisen Dirk J, et al. Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction. Eur J Heart Fail. 2013;15 (1):94-102.
   12. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis. J Amer Coll Cardiology. 2004;43, N 3:317-327.
   13. Jones R, White H, Shaw L, Pietrobon R, et al. STICH (surgical treatment for ischemic heart failure) trial enrollment. J Amer Coll Cardiology. 2010;56:490-498.
   14. Kitzman DW. Heart failure with normal systolic function. In: Rich MW, ed. Clinics in Geriatric Medicine: Heart Failure in the Elderly. Philadelphia, Pa: WB Saunders, 2000:489-511.
   15. Khatibzadeh S, Farzadfar F, Oliver J, et al. Worldwide risk factors for heart failure: a systematic review and pooled analysis. Int J Cardiol. 2013;168 (2):1186-1194.
   16. Krannich JH, Lueger S, Weyers P, Elert O. Health-related quality of life two days before, ten days and one year after coronary artery bypass graft surgery. Thorac Cardiovasc Surg. 2007;55:288-292.
   17. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1-39.
   18. Lenzen MJ, Scholte Op Reimer WJ, Boersma E, et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the Euro Heart Failure Survey. Eur Heart J. 2004;25:1214-1220.
   19. Lewis EF, Lamas GA, O’Meara E, et al. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. Eur J Heart Fail. 2007;9 (1):83-91.
   20. Nalysnyk L, Fahrbach K, Reynolds MW, et al. Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart. 2003;89 (7):767-772.
   21. Rector TS, Cohn JN. Assessment of Patient Outcome with the Minnesota Living with Heart failure Questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J. 1992;124:1017-1025.
   22. Rumsfeld JS, MacWhinney S, McCarthy M. Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. JAMA. 1999;281:1298-1303.
   23. Westin L, Nilstun T, Carlsson R, Erhardt L. Patients with ischemic heart disease: quality of life predicts long-term mortality. Scand Cardiovasc J. 2005;39:50-54.
   24. Yusuf S. Effect of coronary artery bypass graft surgery on survival: overview of 10 year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344 (8934):1446.